Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff Sells 30,000 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan A. Dyckerhoff sold 30,000 shares of the stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $105.90, for a total transaction of $3,177,000.00. Following the completion of the transaction, the director now directly owns 3,765 shares in the company, valued at approximately $398,713.50. This represents a 88.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Astera Labs Stock Down 1.7 %

ALAB opened at $105.48 on Wednesday. Astera Labs, Inc. has a twelve month low of $36.22 and a twelve month high of $113.85. The company has a 50-day simple moving average of $72.05 and a 200 day simple moving average of $60.30.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.17 by $0.06. The company had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm’s revenue was up 47.1% compared to the same quarter last year. Sell-side analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $65.00 target price on shares of Astera Labs in a research report on Wednesday, October 9th. Evercore ISI reduced their price target on Astera Labs from $98.00 to $80.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. increased their price objective on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Craig Hallum boosted their target price on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Finally, Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Buy” and a consensus target price of $94.67.

Institutional Investors Weigh In On Astera Labs

Large investors have recently modified their holdings of the business. Sei Investments Co. acquired a new stake in Astera Labs in the first quarter valued at approximately $952,000. Vanguard Group Inc. acquired a new position in Astera Labs in the 1st quarter worth about $127,268,000. Price T Rowe Associates Inc. MD bought a new position in Astera Labs in the first quarter valued at about $44,514,000. Janus Henderson Group PLC bought a new stake in shares of Astera Labs during the first quarter worth about $20,025,000. Finally, Rokos Capital Management LLP acquired a new position in shares of Astera Labs in the first quarter valued at approximately $1,484,000.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.